Other News To Note
Cytos Biotechnology Ltd., of Zurich, Switzerland, said the Swiss Takeover Board approved an exemption allowing the investors in its CHF37 million (US$40.6 million) recapitalization to hold more than one-third of the company's outstanding shares when the financing closes.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST